Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

FDA revokes EUA for malaria drugs against COVID-19

By Chris Newmarker | June 15, 2020

FDA COVID-19FDA today announced that it has revoked its emergency use authorization allowing doctors to use the malaria drugs hydroxychloroquine and chloroquine to treat COVID-19, citing concerns about the drugs’ efficacy against the virus.

A large, randomized clinical trial in hospitalized patients found the malaria medicines showed no benefit for decreasing the likelihood of death or speeding recovery, according to FDA. Said FDA: “This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19.”

President Donald Trump had previously touted the potential for the malaria drugs to treat the coronavirus, even disclosing that he himself was taking hydroxychloroquine preemptively after coming in contact with people who tested positive for the virus.

There has never been high-quality evidence suggesting that hydroxychloroquine is effective against COVID-19 — and worse, the drugs have serious side effects, Dr. Steven Nissen, a Cleveland Clinic researcher and FDA adviser, told The Associated Press. Nissen said he wouldn’t have granted an EUA in the first place.

 

 

Comments

  1. Ron Apple says

    June 22, 2020 at 4:25 pm

    Harvard has captured 5 unique studies confirming the efficacy of HCLQN therapy. Also, there are 64,000 patient study by the French, and the entire continent of Africa and moving to the East who regularly take these anti-malaria meds have few to no cases.

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

Norway investigating deaths of 23 individuals who received COVID-19 vaccine
COVID-19 vaccine
What’s behind the severe allergic reactions from COVID-19 vaccines?
COVID-19 vaccine
Facial swelling and COVID-19 vaccines: 4 facts
Pfizer BioNTech
Pfizer-BioNTech COVID-19 vaccine apparently effective against ‘UK strain’ 

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards